SeaStar Medical Holding Corp

SeaStar Medical Holding Corp (Nasdaq: LMAO) is a medical device company that completed its de-SPAC merger with LMF Acquisition Opportunities, Inc., a blank-check company that conducted its IPO in 2021. The combined entity operates in the medical technology and critical care sector, developing the Selective Cytopheretic Device, a platform targeting acute kidney injury and systemic inflammation. SeaStar Medical filed an 8-K with the SEC on June 17, 2026, accession number 0001437749-26-020967, reflecting continued post-merger public reporting obligations. The company remains listed on Nasdaq under its distinctive ticker following the close of the business combination. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time SPAC data on SeaStar Medical and hundreds of other transactions.